Related Experiment Video
Updated: Jun 1, 2026
08:17
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis
Madhan Thamilarasan1, Dirk Koczan, Michael Hecker
1Department of Immunology, University of Rostock, Germany. madhangp@gmail.com
Autoimmunity Reviews
|May 31, 2011
Summary
MicroRNAs (miRNAs) show promise as biomarkers for multiple sclerosis (MS). Research highlights specific miRNAs in blood and brain lesions, aiding early diagnosis and targeted MS therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression.
- Dysregulation of miRNAs is implicated in various diseases, including autoimmune disorders.
- Multiple Sclerosis (MS) is a chronic central nervous system autoimmune disease characterized by demyelination.
Purpose of the Study:
- To explore the role of miRNAs as potential biomarkers for Multiple Sclerosis (MS).
- To investigate the diagnostic and predictive potential of specific miRNAs in MS.
- To understand the therapeutic implications of targeting miRNAs in MS.
Main Methods:
- Review of recent studies on miRNA profiling in MS patients.
- Analysis of miRNA expression in blood and central nervous system lesions.
- Examination of data from experimental autoimmune encephalomyelitis (EAE) models.
Main Results:
- Several miRNAs have been identified as potential MS biomarkers.
- miR-145 in blood can differentiate MS patients from healthy individuals.
- miR-155 is upregulated in active MS brain lesions, and its absence confers resistance to EAE.
Conclusions:
- miRNAs represent promising novel biomarkers for MS diagnosis and prognosis.
- Targeting specific miRNAs may offer new therapeutic strategies for MS.
- Further research into miRNA expression patterns can advance understanding and treatment of MS.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...